Active Ingredient: PHENTOLAMINE MESYLATE
Proprietary Name: RYZUMVI
Dosage Form; Route of Administration: SOLUTION; OPHTHALMIC
Strength: EQ 0.75% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217064
Product Number: 001
Approval Date: Sep 25, 2023
Applicant Holder Full Name: FAMYGEN LIFE SCIENCES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
